Pacific Biosciences
PACB
PACB
230 hedge funds and large institutions have $249M invested in Pacific Biosciences in 2026 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 60 increasing their positions, 71 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
4.18% less ownership
Funds ownership: 66.49% → 62.31% (-4.2%)
15% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 71
33% less capital invested
Capital invested by funds: $374M → $249M (-$125M)
Holders
230
Holding in Top 10
1
Calls
$1.17M
Puts
$1.07M
Top Buyers
| 1 | +$3.76M | |
| 2 | +$3.44M | |
| 3 | +$2.12M | |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$1.79M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$1.22M |
Top Sellers
| 1 | -$6.26M | |
| 2 | -$4.86M | |
| 3 | -$4.78M | |
| 4 |
AG
Amiral Gestion
Paris,
France
|
-$3.21M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.84M |
